SCHEMBL30074152

SCHEMBL30074152

CC(=O)Cn1ccc2ccccc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.71
MAPK1 P28482 2/20 0.59
CDK4 P11802 4/20 0.57
CCND1 P24385 4/20 0.57
LMNA P02545 1/20 0.56
NOTUM Q6P988 1/20 0.55
NTSR1 P30989 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
POLB P06746 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9701534 1.00 KMT2A (0.71) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL27602860 0.85 KMT2A (0.65) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL1598786 0.83 KMT2A (1.00) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL29420405 0.83 KMT2A (1.00) KMT2AMAPK1CDK4CCND1LMNA
Acetic Acid SCHEMBL27760597 0.83 KMT2A (0.68) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL12881191 0.82 LMNA (0.71) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL15262402 0.82 KMT2A (0.66) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL15262406 0.82 KMT2A (0.66) KMT2AMAPK1CDK4CCND1LMNA
Hydrochloric Acid SCHEMBL25303352 0.81 KMT2A (0.96) KMT2AMAPK1CDK4CCND1LMNA
SCHEMBL1519806 0.81 KMT2A (0.71) KMT2AMAPK1CDK4CCND1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691959-B2 Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds AVEXXIN AS (NO) 2023-07-04 US disclosed
US-20220363659-A1 ANTI-INFLAMMATORY AND ANTITUMOR 2-OXOTHIAZOLES AND 2-OXOTHIOPHENES COMPOUNDS AVEXXIN AS (NO) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363659-A1 ANTI-INFLAMMATORY AND ANTITUMOR 2-OXOTHIAZOLES AND 2-OXOTHIOPHENES COMPOUNDS OXER1, CASP1, IL6 KMT2A 2837/4885MAPK1 916/4885CDK4 1341/4885
US-11691959-B2 Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds CASP1, IL1B, OXER1 KMT2A 3107/4885MAPK1 879/4885CDK4 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.